Beam Therapeutics Inc. SG&A Expenses

SG&A Expenses of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including SG&A Expenses growth rates and interactive chart. Selling, general and administrative expense (SG&A) is reported on the income statement as the sum of all direct and indirect selling expenses and all general and administrative expenses (G&A) of a company. SG&A, also known as SGA, includes all the costs not directly tied to making a product or performing a service. That is, SG&A includes the costs to sell and deliver products and services and the costs to manage the company. It includes administrative

Highlights and Quick Summary

  • SG&A Expenses for the quarter ending September 30, 2022 was $21.8 Million (a -9.34% decrease compared to previous quarter)
  • Year-over-year quarterly SG&A Expenses increased by 22.75%
  • Annual SG&A Expenses for 2021 was $57.2 Million (a 93.28% increase from previous year)
  • Annual SG&A Expenses for 2020 was $29.6 Million (a 44.04% increase from previous year)
  • Annual SG&A Expenses for 2019 was $20.6 Million (a 73.18% increase from previous year)
  • Twelve month SG&A Expenses ending September 30, 2022 was $82.9 Million (a 7.86% increase compared to previous quarter)
  • Twelve month trailing SG&A Expenses increased by 44.87% year-over-year
Trailing SG&A Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$82.9 Million $76.9 Million $66.2 Million $57.2 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical SG&A Expenses of Beam Therapeutics Inc.

Most recent SG&A Expensesof BEAM including historical data for past 10 years.

Interactive Chart of SG&A Expenses of Beam Therapeutics Inc.

Beam Therapeutics Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $21.82 $24.06 $19.25 –
2021 $17.77 $15.77 $13.4 $10.27 $57.22
2020 $8.35 $7.5 $6.94 $6.81 $29.61
2019 $6.16 $5.49 $4.98 $3.93 $20.55
2018 – – – – $11.87
2017 – – – – $2.01

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com